Cited by 276Sleep and related disordersObstructive Sleep Apnea ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Sleep Symptoms Predict the Development of the Metabolic Syndrome

Open access
Troxel, Wendy M., Buysse, Daniel J., Matthews, Karen A., Kip, Kevin E., Strollo, Patrick J., Hall, Martica, Drumheller, Oliver, Reis, Steven E.·2010·Sleep

Abstract

BACKGROUND: Sleep complaints are highly prevalent and associated with cardiovascular disease (CVD) morbidity and mortality. This is the first prospective study to report the association between commonly reported sleep symptoms and the development of the metabolic syndrome, a key CVD risk factor. METHODS: Participants were from the community-based Heart Strategies Concentrating on Risk Evaluation study. The sample was comprised of 812 participants (36% African American; 67% female) who were free of metabolic syndrome at baseline, had completed a baseline sleep questionnaire, and had metabolic syndrome evaluated 3 years after baseline. Apnea-hypopnea index (AHI) was measured cross-sectionally using a portable monitor in a subset of 290 participants. Logistic regression examined the risk of developing metabolic syndrome and its components according to individual sleep symptoms and insomnia syndrome. RESULTS: Specific symptoms of insomnia (difficulty falling asleep [DFA] and "unrefreshing" sleep), but not a syndromal definition of insomnia, were significant predictors of the development of metabolic syndrome. Loud snoring more than doubled the risk of developing the metabolic syndrome and also predicted specific metabolic abnormalities (hyperglycemia and low high-density lipoprotein cholesterol). With further adjustment for AHI or the number of metabolic abnormalities at baseline, loud snoring remained a significant predictor of metabolic syndrome, whereas DFA and unrefreshing sleep were reduced to marginal significance. CONCLUSION: Difficulty falling asleep, unrefreshing sleep, and, particularly, loud snoring, predicted the development of metabolic syndrome in community adults. Evaluating sleep symptoms can help identify individuals at risk for developing metabolic syndrome.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/sleep/33.12.1633

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Hedner J, Wilcox I, Sullivan C. Speculations on the interaction between vascular disease and obstructive sleep apnoea. In: Saunders NA, Sullivan C, eds. Sleep and Breathing. New York: Dekker; 1994:823-46.
  2. O'Connor GT, Caffo B, Newman A, B., et al. Prospective study of sleep- disordered breathing and hypertension. Am J Respir Crit Care Med 2009;179:1159-64.
  3. Wang Y, Teschler T, Weinreich G, Hess S, Wessendorf TE, Teschler H. Validation of microMESAM as screening device for sleep disordered breathing. Pneumologie 2003;57:734-40.

Cited by

Sorted by citations

Authors
Troxel, W. M., Buysse, D. J., Matthews, K. A., Kip, K. E., Strollo, P. J., Hall, M., Drumheller, O., & Reis, S. E.
Affiliations
  • University of Pittsburgh (US)
  • University of South Florida (US)
Corresponding author
Troxel, Wendy M.
Venue
Sleep
Published
2010-12
Volume
33
Issue
12
Pages
1633-1640
ISSN
  • 0161-8105 (ISSN-L)
  • 1550-9109
OpenAlex
W137944412
Cited by
276
References
32
Citations by year
2026: 4 · 2025: 18 · 2024: 23 · 2023: 19 · 2022: 19 · 2021: 21 · 2020: 19 · 2019: 23 · 2018: 15 · 2017: 21 · 2016: 19 · 2015: 14 · 2014: 17 · 2013: 19 · 2012: 16
FWCI
18.32
Type
journal article
Language
en
Open access
Locations
  • SLEEP (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Eli Lilly and Company
  • Pfizer (RR024153)
  • GlaxoSmithKline (RR024153)
  • Sanofi
  • Pennsylvania Department of Health (HL076852, ME-02-384, RR024153)
  • Georgia Clinical and Translational Science Alliance
  • ResMed
  • National Institutes of Health (ME-02-384, HL076852, RR024153)
  • National Heart, Lung, and Blood Institute (HL 076858, HL 076852, R24HL076852, K23HL093220, R24HL076858)
  • National Center for Research Resources (RR-024153, UL1RR024153)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Physiology › Obstructive Sleep Apnea Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
sleep symptoms, metabolic syndrome, insomnia, difficulty falling asleep, unrefreshing sleep, apnea-hypopnea index, cardiovascular risk, hyperglycemia, low HDL cholesterol, community-dwelling adults
MeSH terms
Aged, Black or African American, Cardiovascular Diseases, Female, Follow-Up Studies, Humans, Male, Middle Aged, Risk Factors, Sex Factors, Sleep Wake Disorders, Metabolic Syndrome, White People

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review